Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Moon

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
European Urology Open Science|August 7, 2023
RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is PlannedDinesh K Agarwal, Clancy Mulholland, Digsu N Koye, et al.
BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL StudyCristian Udovicich, Mathias Bressel, Jamil Manji, et al.
World Journal of Urology|June 2, 2021
<sup>68</sup>Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trialPatrick Bowden, Andrew W See, Kevin So, et al.
European Urology|December 26, 2021
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT TrialShankar Siva, Mathias Bressel, Simon T Wood, et al.
The Lancet. Oncology|May 17, 2026
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trialsShankar Siva, Muhammad Ali, Nicholas Hardcastle, et al.
Cancers|January 11, 2024
Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological OutcomesNiranjan J Sathianathen, Marc A Furrer, Clancy J Mulholland, et al.
World Journal of Urology|July 22, 2022
Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI databaseGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
World Journal of Urology|October 6, 2022
Perioperative outcomes following robot-assisted partial nephrectomy in elderly patientsGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
Journal for Immunotherapy of Cancer|June 28, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genesAnna Sofia Trigos, Anupama Pasam, Patricia Banks, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
European Urology Open Science|August 7, 2023
RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is PlannedDinesh K Agarwal, Clancy Mulholland, Digsu N Koye, et al.
BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL StudyCristian Udovicich, Mathias Bressel, Jamil Manji, et al.
World Journal of Urology|June 2, 2021
<sup>68</sup>Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trialPatrick Bowden, Andrew W See, Kevin So, et al.
European Urology|December 26, 2021
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT TrialShankar Siva, Mathias Bressel, Simon T Wood, et al.
The Lancet. Oncology|May 17, 2026
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trialsShankar Siva, Muhammad Ali, Nicholas Hardcastle, et al.
Cancers|January 11, 2024
Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological OutcomesNiranjan J Sathianathen, Marc A Furrer, Clancy J Mulholland, et al.
World Journal of Urology|July 22, 2022
Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI databaseGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
World Journal of Urology|October 6, 2022
Perioperative outcomes following robot-assisted partial nephrectomy in elderly patientsGopal Sharma, Milap Shah, Puneet Ahluwalia, et al.
Journal for Immunotherapy of Cancer|June 28, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genesAnna Sofia Trigos, Anupama Pasam, Patricia Banks, et al.
Pageof 11